IRadimed Corporation (IRMD)
USD 49.54
(-3.54%)
USD 49.54
(-3.54%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 65.56 Million USD | 23.0% |
| 2022 | 53.3 Million USD | 27.48% |
| 2021 | 41.81 Million USD | 31.83% |
| 2020 | 31.71 Million USD | -17.65% |
| 2019 | 38.51 Million USD | 26.54% |
| 2018 | 30.43 Million USD | 31.88% |
| 2017 | 23.08 Million USD | -28.97% |
| 2016 | 32.49 Million USD | 2.86% |
| 2015 | 31.59 Million USD | 101.84% |
| 2014 | 15.65 Million USD | 38.03% |
| 2013 | 11.34 Million USD | 47.56% |
| 2012 | 7.68 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 17.92 Million USD | 1.88% |
| 2024 Q1 | 17.59 Million USD | 0.84% |
| 2024 Q3 | 18.32 Million USD | 2.21% |
| 2023 Q2 | 16.13 Million USD | 4.23% |
| 2023 FY | 65.56 Million USD | 23.0% |
| 2023 Q1 | 15.47 Million USD | 4.11% |
| 2023 Q4 | 17.45 Million USD | 5.74% |
| 2023 Q3 | 16.5 Million USD | 2.32% |
| 2022 Q2 | 12.72 Million USD | 3.34% |
| 2022 Q1 | 12.31 Million USD | 3.69% |
| 2022 FY | 53.3 Million USD | 27.48% |
| 2022 Q4 | 14.86 Million USD | 10.86% |
| 2022 Q3 | 13.4 Million USD | 5.39% |
| 2021 Q1 | 9.22 Million USD | 7.93% |
| 2021 Q2 | 9.81 Million USD | 6.36% |
| 2021 FY | 41.81 Million USD | 31.83% |
| 2021 Q3 | 10.9 Million USD | 11.18% |
| 2021 Q4 | 11.87 Million USD | 8.85% |
| 2020 Q3 | 7.69 Million USD | 13.31% |
| 2020 Q4 | 8.54 Million USD | 11.0% |
| 2020 FY | 31.71 Million USD | -17.65% |
| 2020 Q1 | 8.67 Million USD | -20.32% |
| 2020 Q2 | 6.79 Million USD | -21.7% |
| 2019 FY | 38.51 Million USD | 26.54% |
| 2019 Q1 | 8.43 Million USD | 1.18% |
| 2019 Q4 | 10.89 Million USD | 9.31% |
| 2019 Q3 | 9.96 Million USD | 8.0% |
| 2019 Q2 | 9.22 Million USD | 9.34% |
| 2018 Q4 | 8.33 Million USD | 9.52% |
| 2018 Q2 | 7.37 Million USD | 3.78% |
| 2018 Q1 | 7.1 Million USD | 6.01% |
| 2018 FY | 30.43 Million USD | 31.88% |
| 2018 Q3 | 7.61 Million USD | 3.22% |
| 2017 Q2 | 5.52 Million USD | 7.01% |
| 2017 Q4 | 6.7 Million USD | 17.84% |
| 2017 FY | 23.08 Million USD | -28.97% |
| 2017 Q1 | 5.16 Million USD | -13.82% |
| 2017 Q3 | 5.68 Million USD | 2.99% |
| 2016 Q1 | 8.96 Million USD | 1.87% |
| 2016 FY | 32.49 Million USD | 2.86% |
| 2016 Q4 | 5.99 Million USD | -21.93% |
| 2016 Q3 | 7.67 Million USD | -22.25% |
| 2016 Q2 | 9.86 Million USD | 10.09% |
| 2015 Q3 | 8.19 Million USD | 7.68% |
| 2015 Q2 | 7.6 Million USD | 8.83% |
| 2015 Q1 | 6.99 Million USD | 95.11% |
| 2015 FY | 31.59 Million USD | 101.84% |
| 2015 Q4 | 8.79 Million USD | 7.39% |
| 2014 FY | 15.65 Million USD | 38.03% |
| 2014 Q4 | 3.58 Million USD | -5.99% |
| 2014 Q1 | 3.55 Million USD | 2.9% |
| 2014 Q2 | 4.7 Million USD | 32.14% |
| 2014 Q3 | 3.81 Million USD | -18.9% |
| 2013 FY | 11.34 Million USD | 47.56% |
| 2013 Q2 | 2.77 Million USD | 5.58% |
| 2013 Q4 | 3.45 Million USD | 39.41% |
| 2013 Q3 | 2.47 Million USD | -10.64% |
| 2013 Q1 | 2.62 Million USD | 0.0% |
| 2012 FY | 7.68 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -443.679% |
| BrainsWay Ltd. | 31.78 Million USD | -106.268% |
| Cerus Corporation | 156.36 Million USD | 58.072% |
| Envoy Medical, Inc. | 316 Thousand USD | -20647.562% |
| electroCore, Inc. | 16.03 Million USD | -308.997% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -10080.481% |
| IceCure Medical Ltd | 3.22 Million USD | -1930.421% |
| Inogen, Inc. | 315.66 Million USD | 79.23% |
| OrthoPediatrics Corp. | 148.73 Million USD | 55.919% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -2600.259% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -17862.322% |
| MaxCyte, Inc. | 41.28 Million USD | -58.793% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -3257.966% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -59099.53% |
| Orthofix Medical Inc. | 746.64 Million USD | 91.219% |
| PAVmed Inc | 2.45 Million USD | -2573.829% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -191.142% |
| RxSight, Inc. | 89.07 Million USD | 26.398% |
| Sight Sciences, Inc. | 81.05 Million USD | 19.115% |
| SI-BONE, Inc. | 138.88 Million USD | 52.794% |
| TELA Bio, Inc. | 58.45 Million USD | -12.162% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 64.962% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -375.055% |
| Acutus Medical, Inc. | 7.16 Million USD | -815.163% |
| Talis Biomedical Corporation | 412 Thousand USD | -15813.179% |
| Spectral AI, Inc. | 18.05 Million USD | -263.105% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -561.911% |
| CVRx, Inc. | 39.29 Million USD | -66.846% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -6668.028% |
| Bioventus Inc. | 512.34 Million USD | 87.203% |
| Venus Concept Inc. | 76.35 Million USD | 14.134% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -254.18% |
| LivaNova PLC | 1.15 Billion USD | 94.316% |
| 908 Devices Inc. | 50.22 Million USD | -30.527% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 86.405% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -84997.212% |
| NeuroPace, Inc. | 65.42 Million USD | -0.216% |
| LENSAR, Inc. | 42.16 Million USD | -55.494% |
| Apyx Medical Corporation | 52.34 Million USD | -25.241% |
| Cutera, Inc. | 212.36 Million USD | 69.128% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -96.541% |
| BioSig Technologies, Inc. | 18 Thousand USD | -364134.978% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 60.662% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -173.689% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 95.747% |
| Axonics, Inc. | 366.37 Million USD | 82.105% |
| Outset Medical, Inc. | 130.37 Million USD | 49.713% |
| IRIDEX Corporation | 51.86 Million USD | -26.4% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 51.86% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -5475.025% |
| INVO Bioscience, Inc. | 3.02 Million USD | -2070.524% |
| Telesis Bio, Inc. | 27.5 Million USD | -138.33% |
| Viemed Healthcare, Inc. | 183 Million USD | 64.175% |
| Varex Imaging Corporation | 811 Million USD | 91.916% |
| Quipt Home Medical Corp. | 221.74 Million USD | 70.433% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 4.533% |
| Dynatronics Corporation | 32.53 Million USD | -101.52% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -655.5% |
| Semler Scientific, Inc. | 68.18 Million USD | 3.845% |
| InMode Ltd. | 492.04 Million USD | 86.676% |
| Bruker Corporation | 2.96 Billion USD | 97.788% |
| Cytosorbents Corporation | 36.34 Million USD | -80.367% |
| DexCom, Inc. | 3.62 Billion USD | 98.19% |
| Align Technology, Inc. | 3.86 Billion USD | 98.302% |
| Viveve Medical, Inc. | 6.42 Million USD | -920.266% |
| ZimVie Inc. | 457.43 Million USD | 85.667% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 66.033% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -59099.53% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 91.232% |
| Profound Medical Corp. | 7.33 Million USD | -794.313% |
| Insulet Corporation | 1.69 Billion USD | 96.137% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 47.999% |
| iCAD, Inc. | 17.31 Million USD | -278.579% |
| Nuwellis, Inc. | 8.86 Million USD | -639.647% |
| Biotricity, Inc. | 12.06 Million USD | -443.484% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 86.693% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -956.604% |
| PAVmed Inc. | 2.45 Million USD | -2573.829% |
| BIOLASE, Inc. | 49.16 Million USD | -33.354% |
| Beyond Air, Inc. | 1.15 Million USD | -5556.799% |
| FONAR Corporation | 102.88 Million USD | 36.276% |
| AxoGen, Inc. | 159.01 Million USD | 58.769% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 76.109% |
| Inari Medical, Inc. | 493.63 Million USD | 86.718% |
| UFP Technologies, Inc. | 400.07 Million USD | 83.612% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -352385.462% |
| Tenon Medical, Inc. | 2.92 Million USD | -2139.149% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -862.448% |
| AdaptHealth Corp. | 3.2 Billion USD | 97.951% |
| Sintx Technologies, Inc. | 2.62 Million USD | -2395.71% |
| NanoVibronix, Inc. | 2.28 Million USD | -2771.761% |
| Quanterix Corporation | 122.36 Million USD | 46.422% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -168.643% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 67.304% |
| TransMedics Group, Inc. | 241.62 Million USD | 72.866% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -373.237% |
| NeuroMetrix, Inc. | 5.9 Million USD | -1010.957% |
| Hyperfine, Inc. | 11.03 Million USD | -494.292% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 60.302% |
| Biomerica, Inc. | 5.41 Million USD | -1110.753% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -29.67% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 62.987% |